Among them, BCL2-associated athanogene 3 (BAG3) gene mutation is thought to induce a rare MFM subtype VI with clinical features of rapidly progressive limb and axial muscle weakness, cardiomyopathy, and respiratory insufficiency in childhood. Here, BAG3 is linked to cardiomyopathy.